These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 28634902)

  • 1. Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.
    Li Y; Zhao J; Hölscher C
    CNS Drugs; 2017 Aug; 31(8):639-652. PubMed ID: 28634902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroprotective effect of baicalein in patients with Parkinson's disease].
    Yu X; He G; Du G
    Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(4):421-5. PubMed ID: 22667137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons.
    Li FQ; Wang T; Pei Z; Liu B; Hong JS
    J Neural Transm (Vienna); 2005 Mar; 112(3):331-47. PubMed ID: 15503194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological properties of baicalein in cardiovascular system.
    Huang Y; Tsang SY; Yao X; Chen ZY
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):177-84. PubMed ID: 15853750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein as a potent neuroprotective agent: A review.
    Sowndhararajan K; Deepa P; Kim M; Park SJ; Kim S
    Biomed Pharmacother; 2017 Nov; 95():1021-1032. PubMed ID: 28922719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation.
    Lu JH; Ardah MT; Durairajan SS; Liu LF; Xie LX; Fong WF; Hasan MY; Huang JD; El-Agnaf OM; Li M
    Chembiochem; 2011 Mar; 12(4):615-24. PubMed ID: 21271629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis.
    Zhang X; Du L; Zhang W; Yang Y; Zhou Q; Du G
    Sci Rep; 2017 Aug; 7(1):9968. PubMed ID: 28855526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP
    Hung KC; Huang HJ; Wang YT; Lin AM
    J Ethnopharmacol; 2016 Dec; 194():522-529. PubMed ID: 27742410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.
    Jiang T; Sun Q; Chen S
    Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile.
    Cheng Y; He G; Mu X; Zhang T; Li X; Hu J; Xu B; Du G
    Neurosci Lett; 2008 Aug; 441(1):16-20. PubMed ID: 18586394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice.
    Kim DH; Hossain MA; Kang YJ; Jang JY; Lee YJ; Im E; Yoon JH; Kim HS; Chung HY; Kim ND
    Int J Oncol; 2013 Nov; 43(5):1652-8. PubMed ID: 24008356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we prevent Parkinson's and Alzheimer's disease?
    Kedar NP
    J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of baicalein in animal models of Parkinson's disease: A systematic review of experimental studies.
    Zhu Q; Zhuang X; Lu J
    Phytomedicine; 2019 Mar; 55():302-309. PubMed ID: 30385133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson's disease: A microarray study.
    Gao L; Li C; Yang RY; Lian WW; Fang JS; Pang XC; Qin XM; Liu AL; Du GH
    Pharmacol Biochem Behav; 2015 Jun; 133():155-63. PubMed ID: 25895692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease.
    Kim SW; Lee JH; Kim B; Yang G; Kim JU
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
    Javed H; Mohamed Fizur NM; Jha NK; Ashraf GM; Ojha S
    Curr Neuropharmacol; 2023; 21(6):1421-1432. PubMed ID: 36567278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Pharmacol Res; 2019 Aug; 146():104336. PubMed ID: 31271846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.